Privi Speciality Chemicals shareholding pattern

PRIVISCL

2799.6

48.30 (1.76%)
Last updated on 12 Feb, 2026 | 15:48 IST
alert_iconwatchlist_icon
BUYSELL

alert_iconThe current prices are delayed, login to your account for live prices

Privi Speciality Chemicals Shareholding Pattern

  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
Total Promoters
Segment
Percent

Total Promoters

74.05%

Mutual Fund

1.58%

Insurance

0%

Foreign Institutional Investors

0.48%

Domestic Institutional Investors

0.51%

Retail

23.38%

Others

0%

Total Promoters
MAR '24
74.05%
JUN '24
74.05%
SEP '24
74.05%
DEC '24
74.05%

Summary

For Year 2025-26, Privi Speciality Chemicals reports the following shareholding: Total Promoters at 60.6%, Mutual Fund at 9.64%, Insurance at 0%, Foreign Institutional Investors at 1.64%, Domestic Institutional Investors at 0.6%, and Retail at 27.52%. This breakdown provides a quick snapshot of ownership distribution for Privi Speciality Chemicals in 2025-26.

Privi Speciality Chemicals FAQs

As of 02-2026, the promoter shareholding in Privi Speciality Chemicals stands at 60.6% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.

The FII and DII shareholding of Privi Speciality Chemicals is 1.64% and 0.6% respectively.

The retail shareholding of the Privi Speciality Chemicals is 27.52%.

Changes in shareholding patterns of Privi Speciality Chemicals can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.

Shareholding patterns of Privi Speciality Chemicals are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.

The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.